APA (7th ed.) Citation

AE, S., K, W., MR, G., K, A., S, C., PY, W., . . . MP, M. (2024). NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma. Neuro-oncology, 26(9), 1628. https://doi.org/10.1093/neuonc/noae058

Chicago Style (17th ed.) Citation

AE, Sloan, et al. "NRG-BN002: Phase I Study of Ipilimumab, Nivolumab, and the Combination in Patients with Newly Diagnosed Glioblastoma." Neuro-oncology 26, no. 9 (2024): 1628. https://doi.org/10.1093/neuonc/noae058.

MLA (9th ed.) Citation

AE, Sloan, et al. "NRG-BN002: Phase I Study of Ipilimumab, Nivolumab, and the Combination in Patients with Newly Diagnosed Glioblastoma." Neuro-oncology, vol. 26, no. 9, 2024, p. 1628, https://doi.org/10.1093/neuonc/noae058.